TEPEZZA (teprotumumab)
500 mg/1 · Lyophilized Injection Powder
By Horizon Therapeutics USA, Inc.
- NDC
- 75987-130
- Route
- Intravenous
- Therapeutic class
- Insulin-like Growth Factor-1 Receptor Inhibitor , Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]
- Marketing category
- BLA
Package sizes
- 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSENDC 75987-130-15Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Diabetes & Endocrine
See all →
OMEOSPORT
Pellet
Guna spa
Available to source

GUNA-GERIATRICS
Solution / Drops
Guna spa
Available to source

PROCORT (1.85% hydrocortisone acetate - 1.15% pramoxine hci cream)
18.5 mg/g / 11.5 mg/g · Cream
Womens Choice Pharmaceuticals LLC
Available to source

Equate Hydrocortione (1% Hydrocortisone)
10 mg/g · Cream
Walmart Inc.
Available to source
